Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NVAX save search
BioSpace Movers & Shakers, April 1
Published: 2022-04-01 (Crawled : 15:00) - biospace.com/
RCOR | $3.2 0.0%
|
|
| O: 0.0%
H: 3.19%
C: -4.01%
WMT | News | $59.53 0.46% 0.0% 14M
|
Retail Trade
|
| O: 0.5%
H: 1.08%
C: 0.9%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.64%
H: 0.6%
C: 0.57%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.39%
H: 0.0%
C: 0.0%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.22%
H: 1.01%
C: 0.86%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.41%
H: 0.11%
C: -0.22%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.31%
H: 0.0%
C: 0.0%
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -0.48%
H: 4.07%
C: 1.39%
NKTX | $7.26 -6.8% -7.3% 730K
|
Health Technology
|
| O: -1.23%
H: 4.98%
C: 1.78%
ALEC | $5.1 0.2% 0.2% 470K
|
Health Technology
|
| O: -0.21%
H: 2.39%
C: -1.05%
Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17)
Published: 2022-03-31 (Crawled : 11:00) - prnewswire.com
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 2.21%
H: 0.0%
C: -3.6%
covid-19 vaccine authorization
Renovacor Announces the Appointment of Fred Driscoll as Chief Financial Officer
Published: 2022-03-28 (Crawled : 12:20) - biospace.com/
RCOR | $3.2 0.0%
|
|
| O: -2.6%
H: 4.61%
C: 4.37%
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 0.86%
H: 4.49%
C: -1.23%
Novavax Announces Participation in Two Booster Studies Using its COVID-19 Vaccine
Published: 2022-03-25 (Crawled : 13:20) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -0.09%
H: 0.04%
C: -8.91%
covid-19 vaccine
Novavax and Serum Institute of India Announce First Emergency Use Authorization of Novavax' COVID-19 Vaccine in Adolescents ≥12 to & 18 in India
Published: 2022-03-22 (Crawled : 23:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -0.64%
H: 9.36%
C: 7.35%
covid-19 authorization india vaccine emergency use authorization
New Variants Throw the Spotlight on Booster Shots of COVID-19 Vaccines - According to New Research from StrategyR
Published: 2022-03-10 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.52%
H: 1.67%
C: 1.67%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -1.99%
H: 2.84%
C: 0.35%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -2.09%
H: 0.95%
C: 0.01%
covid-19 research covid vaccine
Novavax Announces Extended Durability of Protection Against Infection and Disease in United Kingdom COVID-19 Vaccine Phase 3 Clinical Trial
Published: 2022-02-28 (Crawled : 23:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -0.81%
H: 3.12%
C: 2.96%
covid-19 trial covid disease vaccine infection phase 3 infections
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights on February 28, 2022
Published: 2022-02-21 (Crawled : 22:00) - prnewswire.com
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -3.09%
H: 4.17%
C: 0.04%
financial results conference results
Health Canada Authorizes Novavax COVID-19 Vaccine
Published: 2022-02-17 (Crawled : 17:00) - prnewswire.com
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -0.72%
H: 3.37%
C: -2.9%
covid-19 health covid vaccine
Singapore Health Sciences Authority Issues Interim Authorization for Novavax COVID-19 Vaccine
Published: 2022-02-14 (Crawled : 23:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -3.44%
H: 2.07%
C: -7.82%
covid-19 health covid authorization vaccine
Novavax Files for Conditional Marketing Authorization of COVID-19 Vaccine in Switzerland
Published: 2022-02-14 (Crawled : 14:30) - prnewswire.com
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -3.44%
H: 2.07%
C: -7.82%
covid-19 covid authorization switzerland vaccine
Novavax to Participate in Fireside Chat at the 11th Annual SVB Leerink Global Healthcare Conference
Published: 2022-02-11 (Crawled : 15:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 3.19%
H: 0.0%
C: 0.0%
health thc conference svb leerink global
Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial
Published: 2022-02-10 (Crawled : 00:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -4.98%
H: 0.0%
C: 0.0%
covid-19 trial covid event-19 positive results positive vaccine phase 3
New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine
Published: 2022-02-03 (Crawled : 23:00) - prnewswire.com
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -0.2%
H: 3.78%
C: 1.16%
covid-19 approval covid vaccine grant granted
Global COVID-19 Vaccines Market Report 2022: Leading Vaccine Companies Stress on Booster Dose
Published: 2022-02-02 (Crawled : 21:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -4.8%
H: 4.69%
C: -0.33%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -3.66%
H: 3.05%
C: -0.68%
covid-19 covid report vaccine
Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine
Published: 2022-01-31 (Crawled : 19:00) - prnewswire.com
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 4.0%
H: 1.41%
C: -2.33%
covid-19 fda covid authorization vaccine merge emergency use authorization
Novavax and Israel Announce Advance Purchase Agreement for Supply of COVID-19 Vaccine
Published: 2022-01-28 (Crawled : 14:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 3.41%
H: 10.13%
C: 9.96%
covid-19 israel covid vaccine nvx-cov2373
Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine
Published: 2022-01-19 (Crawled : 01:00) - prnewswire.com
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 2.59%
H: 3.89%
C: -4.6%
covid-19 covid tga australia vaccine granted grant
South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine
Published: 2022-01-12 (Crawled : 12:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -2.2%
H: 3.46%
C: -0.75%
drug vaccine covid food
JW Therapeutics Announces Two Appointments to Strengthen R&D Capability and Pipeline Building
Published: 2022-01-10 (Crawled : 06:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 3.9%
H: 9.08%
C: 6.97%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.